Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19055 | 26797396 | Am J Physiol Gastrointest Liver Physiol | Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice. | 2016 | Details |
| A19056 | 26796885 | World J Surg | Cholecystectomy Causes Ultrasound Evidence of Increased Hepatic Steatosis. | 2016 | Details |
| A19057 | 26794269 | Nat Rev Drug Discov | Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. | 2016 | Details |
| A19058 | 26794005 | J Gastroenterol | Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice. | 2016 | Details |
| A19059 | 26792853 | QJM | Association between non-alcoholic hepatic steatosis and hyper reactive blood pressure response on the exercise treadmill test. | 2016 | Details |
| A19060 | 26791408 | J Transl Med | The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women. | 2016 | Details |
| A19061 | 26791191 | Am J Clin Nutr | Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level. | 2016 | Details |
| A19063 | 26788524 | J Diabetes Res | A Novel Wistar Rat Model of Obesity-Related Nonalcoholic Fatty Liver Disease Induced by Sucrose-Rich Diet. | 2015 | Details |
| A19064 | 26787197 | Obes Surg | Severe Vitamin D Deficiency Is Not Associated with Liver Damage in Morbidly Obese Patients. | 2016 | Details |
| A19066 | 26786607 | Sao Paulo Med J | Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional study. | 2016 | Details |
| A19067 | 26786351 | Int J Obes (Lond) | Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention. | 2016 | Details |
| A19068 | 26785389 | Hepatol Res | The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. | 2016 | Details |
| A19069 | 26784973 | Scand J Gastroenterol | Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease. | 2016 | Details |
| A19070 | 26784271 | Aliment Pharmacol Ther | Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer. | 2016 | Details |
| A19073 | 26783552 | Cell Mol Gastroenterol Hepatol | Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ. | 2015 | Details |
| A19074 | 26783443 | Clin Case Rep | Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia. | 2015 | Details |
| A19075 | 26780287 | J Hepatol | Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A19076 | 26778709 | Cytokine | Homeostasis of IL-15 dependent lymphocyte subsets in the liver. | 2016 | Details |
| A19077 | 26778339 | Clin Nutr | The odd-carbon medium-chain fatty triglyceride triheptanoin does not reduce hepatic steatosis. | 2015 | Details |
| A19078 | 26775807 | Sci Rep | Dietary component isorhamnetin is a PPARγ antagonist and ameliorates metabolic disorders induced by diet or leptin deficiency. | 2016 | Details |
| A19079 | 26775764 | Nat Rev Endocrinol | The Framingham Heart Study--67 years of discovery in metabolic disease. | 2016 | Details |
| A19082 | 26775559 | Metabolism | Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2015 | Details |
| A19083 | 26775542 | Biosci Biotechnol Biochem | Long-term fatty liver-induced insulin resistance in orotic acid-induced nonalcoholic fatty liver rats. | 2016 | Details |
| A19084 | 26774456 | Biochem Pharmacol | Coral calcium hydride prevents hepatic steatosis in high fat diet-induced obese rats: A potent mitochondrial nutrient and phase II enzyme inducer. | 2016 | Details |
| A19085 | 26773785 | Nutr Res | Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease. | 2015 | Details |
| A19086 | 26773781 | Nutr Res | Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease. | 2015 | Details |
| A19087 | 26773359 | Environ Toxicol Pharmacol | Di(2-ethylhexyl) phthalate exacerbates non-alcoholic fatty liver in rats and its potential mechanisms. | 2015 | Details |
| A19088 | 26773297 | Hepatology | Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | 2016 | Details |
| A19089 | 26773011 | Adv Nutr | Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. | 2016 | Details |
| A19090 | 26771611 | Int J Mol Sci | Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation. | 2016 | Details |
| A19091 | 26770987 | J Diabetes Res | Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19092 | 26770927 | Clin Mol Hepatol | Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study. | 2015 | Details |
| A19093 | 26770926 | Clin Mol Hepatol | Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study. | 2015 | Details |
| A19094 | 26770920 | Clin Mol Hepatol | Imaging findings of mimickers of hepatocellular carcinoma. | 2015 | Details |
| A19095 | 26770473 | Int J Clin Exp Med | Absence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma. | 2015 | Details |
| A19096 | 26770322 | Int J Clin Exp Med | Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway. | 2015 | Details |
| A19097 | 26770315 | Int J Clin Exp Med | Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis. | 2015 | Details |
| A19098 | 26770272 | Therap Adv Gastroenterol | Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis. | 2016 | Details |
| A19099 | 26770262 | Therap Adv Gastroenterol | Practice patterns in NAFLD and NASH: real life differs from published guidelines. | 2016 | Details |
| A19100 | 26769057 | Dig Dis Sci | Role of MicroRNAs in NAFLD/NASH. | 2016 | Details |
| A19101 | 26768633 | Adv Clin Exp Med | The Distribution of Liver Steatosis, Fibrosis, Steatohepatitis and Inflammation Activity in Alcoholics According to FibroMax Test. | 2016 | Details |
| A19102 | 26765961 | Aliment Pharmacol Ther | I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders. | 2016 | Details |
| A19103 | 26764184 | Gastroenterology | Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes. | 2016 | Details |
| A19104 | 26763865 | Hepatol Res | Characteristics of non-obese non-alcoholic fatty liver disease: Effect of genetic and environmental factors. | 2016 | Details |
| A19105 | 26763834 | Hepatol Res | Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study. | 2016 | Details |
| A19106 | 26762655 | Intern Med J | Patterns of service utilisation within Australian hepatology clinics: high prevalence of advanced liver disease. | 2016 | Details |
| A19107 | 26761949 | J Clin Res Pediatr Endocrinol | Sex Hormone-Binding Globulin in Children and Adolescents. | 2015 | Details |
| A19108 | 26761430 | PLoS One | Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible? | 2016 | Details |
| A19109 | 26758497 | J Clin Res Pediatr Endocrinol | Relationship between Neck Circumference and Non-Alcoholic Fatty Liver Disease in Childhood Obesity. | 2015 | Details |
| A19110 | 26758378 | Lipids Health Dis | Replication analysis of genetic association of the NCAN-CILP2 region with plasma lipid levels and non-alcoholic fatty liver disease in Asian and Pacific ethnic groups. | 2016 | Details |
| A19111 | 26756786 | Pediatr Res | Associations of TM6SF2 167K allele with liver enzymes and lipid profile in children: the PANIC Study. | 2016 | Details |
| A19112 | 26756202 | Diabet Med | Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations. | 2016 | Details |
| A19113 | 26755885 | World J Gastroenterol | Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. | 2016 | Details |
| A19114 | 26755867 | World J Gastroenterol | Association between hepatitis B and metabolic syndrome: Current state of the art. | 2016 | Details |
| A19115 | 26755815 | J Investig Med | Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes. | 2015 | Details |
| A19116 | 26754585 | Endocrinol Metab (Seoul) | The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A19117 | 26753695 | Naunyn Schmiedebergs Arch Pharmacol | Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. | 2016 | Details |
| A19118 | 26749582 | Aliment Pharmacol Ther | Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. | 2016 | Details |
| A19120 | 26748629 | J Hepatobiliary Pancreat Sci | Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial. | 2016 | Details |
| A19121 | 26748347 | Atherosclerosis | Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression. | 2015 | Details |
| A19122 | 26745555 | Digestion | Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study. | 2016 | Details |
| A19123 | 26745268 | PLoS One | A Combination of Mitochondrial Oxidative Stress and Excess Fat/Calorie Intake Accelerates Steatohepatitis by Enhancing Hepatic CC Chemokine Production in Mice. | 2016 | Details |
| A19124 | 26745088 | Asian Pac J Cancer Prev | Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases. | 2015 | Details |
| A19125 | 26743949 | Sci Rep | Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults. | 2016 | Details |
| A19126 | 26743335 | Nat Commun | mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2. | 2016 | Details |
| A19127 | 26743295 | Rom J Morphol Embryol | Hepatocellular carcinoma and metabolic diseases - histological perspectives from a series of 14 cases. | 2015 | Details |
| A19129 | 26742762 | Hepatol Int | Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools. | 2016 | Details |
| A19131 | 26740948 | Mol Genet Genomic Med | Genetic analysis of nonalcoholic fatty liver disease within a Caribbean-Hispanic population. | 2015 | Details |
| A19132 | 26739624 | Toxicol Appl Pharmacol | A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen. | 2015 | Details |
| A19133 | 26738417 | Clin Biochem | High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2015 | Details |
| A19134 | 26735337 | Oncotarget | Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease. | 2016 | Details |
| A19135 | 26734800 | Arq Bras Cir Dig | COMPARISON OF HEPATIC PROFILE IN PRE AND POSTOPERATIVE OF BARIATRIC SURGERY: PRIVATE VS PUBLIC NETWORK. | 2016 | Details |
| A19136 | 26733747 | Clujul Med | Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship. | 2015 | Details |
| A19137 | 26733244 | Physiol Rep | Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease. | 2016 | Details |
| A19138 | 26732788 | Nutr J | Metabolic correlates of subcutaneous and visceral abdominal fat measured by ultrasonography: a comparison with waist circumference. | 2016 | Details |
| A19139 | 26732252 | Sci Rep | Aliskiren Reduces Hepatic steatosis and Epididymal Fat Mass and Increases Skeletal Muscle Insulin Sensitivity in High-Fat Diet-Fed Mice. | 2016 | Details |
| A19140 | 26732004 | Clin Lab | The Higher Prevalence of Non-Alcoholic versus Alcoholic Steatohepatitis in Alcoholics. | 2015 | Details |
| A19141 | 26731990 | Clin Lab | Association of APPL1 Gene Polymorphism with Non-Alcoholic Fatty Liver Disease Susceptibility in a Chinese Han Population. | 2015 | Details |
| A19142 | 26731267 | PLoS One | The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice. | 2016 | Details |
| A19143 | 26730275 | World J Hepatol | Management of non-alcoholic fatty liver disease in 2015. | 2015 | Details |
| A19144 | 26728862 | Turk J Gastroenterol | Ovaries are more vulnerable than hepatocytes for insulin resistance and hyperinsulinemia. | 2016 | Details |
| A19145 | 26728692 | J Intern Med | Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia. | 2016 | Details |
| A19146 | 26728273 | BMB Rep | The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities. | 2016 | Details |
| A19147 | 26728181 | J Neuroinflammation | Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model. | 2016 | Details |
| A19148 | 26728044 | BMC Cancer | MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice. | 2016 | Details |
| A19150 | 26727365 | PLoS One | Efficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats. | 2016 | Details |
| A19152 | 26726030 | J Vet Sci | Aristolochia manshuriensis Kom ethyl acetate extract protects against high-fat diet-induced non-alcoholic steatohepatitis by regulating kinase phosphorylation in mouse. | 2016 | Details |
| A19153 | 26725908 | Liver Int | Iron and the liver. | 2016 | Details |
| A19154 | 26725900 | Liver Int | Follow-up of patients with chronic hepatitis C and a sustained viral response. | 2016 | Details |
| A19155 | 26725058 | Dig Dis Sci | Function of Autophagy in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A19156 | 26725002 | Metabolism | Adipokines in nonalcoholic fatty liver disease. | 2015 | Details |
| A19157 | 26724391 | Eur J Pharmacol | Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model. | 2015 | Details |
| A19158 | 26723251 | Biochem Biophys Res Commun | Suppressing cyclooxygenase-2 prevents nonalcoholic and inhibits apoptosis of hepatocytes that are involved in the Akt/p53 signal pathway. | 2015 | Details |
| A19159 | 26722832 | Atherosclerosis | Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population: The Study of Health in Pomerania (SHIP). | 2015 | Details |
| A19160 | 26720346 | Cell Death Dis | Obesity and cancer, a case for insulin signaling. | 2015 | Details |
| A19161 | 26719755 | Nutr Metab (Lond) | Neck circumference as an independent indicator to non-alcoholic fatty liver disease in non-obese men. | 2015 | Details |
| A19162 | 26718936 | J Diabetes Complications | Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study. | 2015 | Details |
| A19163 | 26718771 | Am J Physiol Gastrointest Liver Physiol | Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation. | 2015 | Details |
| A19164 | 26718596 | Mol Med Rep | bZIP transmembrane transcription factor CREBH: Potential role in non-alcoholic fatty liver disease (Review). | 2015 | Details |
| A19165 | 30284430 | Eksp Klin Gastroenterol | [MALABSORPTION FAT-SOLUBLE VITAMINS AND PROSPECTS OF THEIR USE IN LIVER DISEASES]. | 2018 | Details |